Hoshi Iryo-Sanki Co., Ltd. (TYO:7634)
5,300.00
0.00 (0.00%)
Jul 24, 2026, 9:00 AM JST
Hoshi Iryo-Sanki Revenue
In the fiscal year ending March 31, 2026, Hoshi Iryo-Sanki had annual revenue of 15.52B JPY with 2.77% growth. Hoshi Iryo-Sanki had revenue of 4.20B in the quarter ending March 31, 2026, with 1.67% growth.
Revenue
15.52B
Revenue Growth
+2.77%
P/S Ratio
1.07
Revenue / Employee
29.45M
Employees
527
Market Cap
16.56B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 15.52B | 418.00M | 2.77% |
| Mar 31, 2025 | 15.10B | 324.00M | 2.19% |
| Mar 31, 2024 | 14.78B | 999.00M | 7.25% |
| Mar 31, 2023 | 13.78B | 1.01B | 7.89% |
| Mar 31, 2022 | 12.77B | 962.00M | 8.15% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.51T |
| Otsuka Holdings | 2.52T |
| Chugai Pharmaceutical | 1.29T |
| HOYA Corporation | 947.75B |
| Ohki Healthcare Holdings | 360.36B |
| Medius Holdings | 296.86B |
| Satudora Holdings | 100.57B |
| Pharma Foods International | 67.00B |